A director exercised options at Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Richard A. Heyman, a director at Oric Pharmaceuticals (ORIC), exercised 3,500 options at an exercise price of Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Richard A. Heyman, a director at Oric Pharmaceuticals (ORIC), exercised 3,500 options at an exercise price of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context